Carvana (NYSE:CVNA | CVNA Price Prediction) is back in the spotlight after a blowout quarter, an S&P 500 induction, and a CEO promising 3 million units at 13.5% adjusted EBITDA margins by the next decade. But the details beneath the headline deserve a closer look.
The Hype Trade Is Already Cracking
Carvana is the textbook crowded trade. The stock trades at a trailing P/E of 42 and a forward P/E of 51, with a beta of 3.55 that screams “sell first, ask later” the moment sentiment turns. It already is turning. Shares are down 13.51% year to date and 7.97% over the past month, with the stock now trading below both its 50-day and 200-day moving averages.
Look under the hood and the Q4 fireworks lose their shine. That headline net income was juiced by a $618 million non-cash tax benefit, the balance sheet still carries $4.83 billion in long-term debt plus a $2.23 billion tax receivable agreement liability, and CEO Ernie Garcia keeps trimming his stake through a pre-arranged plan. With sticky inflation squeezing the middle class and credit card delinquencies climbing, a debt-fueled used-car platform with roughly 1.5% market share and zero dividend carries elevated risk for retirement-oriented portfolios.
The Cash Cow Hiding in Plain Sight
Contrast that with Altria (NYSE:MO), the tobacco giant quietly compounding while everyone chases the auto e-tailer. At $69.58, Altria is up 22.68% year to date and 25.23% over the past year, trading at a P/E of 15 and a forward P/E of 12 with a beta of 0.519. Three reasons it stands out for income-focused investors right now.
1. Inflation-beating pricing power. Despite a tougher consumer, the smokeable segment delivered net price realization of 6.3% with adjusted OCI margins expanding to 65.1%. Marlboro held 59.5% premium share. That is an inelastic demand curve doing exactly what investors need it to do.
2. A cash-cow shareholder return machine. Altria returned $8 billion to shareholders in 2025, paid roughly $1.8 billion in Q1 dividends, and just raised the payout to $1.06 per quarter, the 60th increase in 56 years. The yield sits at 5.84%, with $720 million still authorized on the buyback through December. Total debt-to-EBITDA stands at a healthy 1.9x.
3. Guided, predictable growth. Management reaffirmed full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72 after growing Q1 adjusted EPS by 7.3%. The on! pouch portfolio shipped over 46 million cans, up nearly 18%, while the Oral Tobacco segment cleared $400 million in adjusted OCI at 67.4% margins. CEO Billy Gifford summed it up: “Our highly cash-generative businesses supported significant returns to shareholders through dividends and share repurchases.”
The Bottom Line
Carvana is a momentum vehicle priced for a decade of flawless execution in a fragmented, tariff-exposed industry. Altria is a fortress balance sheet paying retirement investors a near-6% yield to wait, with pricing power that compounds through every inflation cycle. The cash flow story looks more durable than the hype trade.
Top Gaining Stocks
Top Losing Stocks